Enzymatic synthesis of (-)-6-[18F]-Fluoronorepinephrine from 6- [18F]-Fluorodopamine by dopamine β-hydroxylase

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 41, Issue 6, 1998, Pages 503-521

  Lui, Eric ^a   Chirakal, Raman ^a   Firnau, Günter ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

( ) 6 18F Fluoronorepinephrine; Dopamine hydroxylase; Positron Emission Tomography (PET)

Indexed keywords

AMINES; BIOCHEMISTRY; NEUROPHYSIOLOGY; NOREPINEPHRINE; POSITRONS; SUBSTRATES;

(-)-6- [18F]-FLUORONOREPINEPHRINE; ACTIVE AREA; DOPAMINE; DOPAMINE Β-HYDROXYLASE; ENZYMATIC SYNTHESIS; HYDROXYLASES; KINETIC INFORMATION; NUCLEAR CARDIOLOGY; POSITRON EMISSION TOMOGRAPHY; SYMPATHETIC NERVOUS SYSTEMS;

POSITRON EMISSION TOMOGRAPHY;

DOPAMINE BETA MONOOXYGENASE; FLUORINE 18; FLUORONORADRENALIN; NORADRENALIN DERIVATIVE; TRACER; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ARTICLE; BIOSYNTHESIS; DRUG SYNTHESIS; ENANTIOMER; ENZYME ACTIVITY; KINETICS; OPTICAL ROTATION; POSITRON EMISSION TOMOGRAPHY; RADIOCHEMISTRY; STEREOSPECIFICITY; STRUCTURE ANALYSIS;

EID: 0031746027     PISSN: 03624803     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1344(199806)41:6<503::AID-JLCR107>3.0.CO;2-I     Document Type: Article

References (27)

1. Sherwood L. Human Physiology: From Cells to Systems, 2nd ed., West Publishing Company, St. Paul, MN, 1993. pp. 79-103, 197-212.
2. Meredith I.T., Broughton A., Jennings G.L., and Esler M.D. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N. Engl. J. Med. 325: 618-624 (1991)
3. Brush J.E. Jr., Eisenhofer G., Garty M., Stull R., Maron B.J., Cannon R.O. 3d, Panza J.A., Epstein E., and Goldstein D.S. Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy. Circulation 79: 836-844 (1989)
4. Zaga A. and Schwartz P.J. Role of autonomic nervous system in the genesis of early ischemic arrhythmias. J. Cardiovsc. Pharm. 7(Suppl 5): S8-S12 (1985)
5. McGhie A.I, Corbett J.R., Akers M.S., Kulkarni I, Sills M.N., Kremers M., Buja L.M., Durant-Reville M., Parkey R.W., and Willerson J.T. Regional cardiac adrenergic function using I-123-meta-iodobenzylguanidine tomographic imaging after acute myocardial infarction. Am. J. Cardiol. 67: 236-242 (1991)
6. Henderson E.B., Kahn J.K., Corbett J.R., Jansen D.E., Pippin J.J., Kulkami P., Ugolini V., Akers M.S., Hansen C., Buja L.M., Parkey R.W., and Willerson J.T. Abnormal I-123-metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 78: 1192-1199 (1988)
7. Glowniak J., Turner F, Gray L.L., Palac R.T., Lagunas-Solar M.C., and Woodward W.R. Iodine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants. J. Nucl. Med. 30: 1182-1191 (1989)
8. Kannel K.B. and Thomas H.E. Jr. Sudden coronary death: the Framingham study. Ann NY Acad Sci 382: 3-20 (1982)
9. Schwartz P. J. Sympathetic imbalance and cardiac arrhythmia. In: Randall WL, ed. Nervous Control of Cardiac Function, Oxford University Press, New York, 1984. pp.225-252.
10. Epstein S.E., Quyyumi A.A. and Bonow R.O. Sounding board: sudden cardiac death without warning. N. Engl. J. Med. 321: 320-324 (1989)
11. Schwaiger M., Guibourg H., Rosenspire K., McClanaban T., Gallagher K., Hutchins G., and Wieland D.M. Effects of regional myocardial ischemia on sympathetic nervous system as assessed by fluorine-18-metaraminol. J. Nucl. Med. 31: 1352-1357 (1990)
12. Allman K.C., Wieland D.M., Muzik O., Degrado T.R., Wolfe E.R., and Schwaiger M. Carbon-11 hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronal function after acute myocardial infarction in humans. J. Am. Coll. Cardiol. 22: 368-375 (1993)
13. Chieuh C.C., Zukowska-Grojec Z., Kirk K.L., and Kopin I.J. 6-Fluorocatecholamines as false adrenergic neurotransmitters. J. Pharmacol. Exp. Ther. 225(3): 529-533 (1983)
14. 18F]fluoronorepinephrine via the nucleophilic aromatic substitution reaction. J. Med. Chem. 34: 767-771 (1991)
15. 18F]fluorodopamine in baboons: heart uptake, metabolism and the effect of desipramine. J. Nucl. Med. 34:767-771 (1993)
16. Eisenhofer G., Hovevey-Sion D., Kopin I.J., Miletich R., Kirk K.L., Finn R., and Goldstein D.S. Neuronal uptake and metabolism of 2- and 6-fluorodopamine: false neurotransmitters for positron emission tomographic imaging of sympathetically innervated tissues. J. Pharmacol. Exp. Ther. 248(1): 419-427 (1989)
17. Chang P.C., Szemeredi K., Grossman E., Kopin I.J., and Goldstein D.S. Fate of tritiated 6-fluorodopamine in rats: a false neurotransmitter for positron emission tomographic imaging of sympathetic innervation and function. J. Pharmacol. Exp. Ther. 255(2): 809-817 (1990)
18. 18F-labeled 6-fluorodopamine for imaging cardiac sympathetic innervation in humans using positron emission tomography. Nucl. Med. Biol. 23: 41-45 (1996)
19. Creveling C.R., Daly J.W., Witkop B. and Udenfnend S. Substrates and inhibitors of dopamine-β-oxidase. Biochim. et Biophys. Acta 64: 125-134 (1962)
20. Goldstein M. and Contrera J.F. The substrate specificity of phenylamine-β-hydroxylase. J. Biol. Chem. 6(237): 1898-1902 (1962)
21. Kirk K.L. Biochemistry of halogenated neuroactive amines. In: Frieden E ed. Biochemistry of Halogenated Organic Compounds, Plenum Press, New York, 1991. pp. 319-352.
22. Cantacuzene D., Kirk K.L., McCulloh D.H., and Creveling C.R. Effect of fluorine substitution on the agonist specificity of norepinephrine. Science 204(15): 1217-1219 (1979)
23. Goldberg L.I., Kohli J.D., Cantacuzene D., Kirk K.L., and Creveling C.R. Effects of ring fluorination on the cardiovascular actions of dopamine and norepinephrine in the dog. J. Pharmacol. Exp. Ther. 213(3): 509-513 (1980)
24. Goodman L.S. and Gilman A. The Pharmacological Basis of Therapeutics, MacMillan, New York, 1975. p. 477.
25. 18F]fluorodopamine for positron emission tomography studies of sympathetic nervous tissue. J. Med. Chem. 34: 861-863 (1991)
26. Goldstein D.S., Chang P.C., Eisenhofer G., Miletich R., Finn R., Bachen J., Kirk K.L., Bacharach S., and Kopin I.J. Positron emission tomographic imaging of cardiac sympathetic innervation and function. Circulation 81: 1606-1621 (1990)
27. Solin O., and Bergman J., Personal Communication, Accelerator laboratory, Abo Akademi, Porthansgtan 3, FIN-20500 Turku, Finland.